[go: up one dir, main page]

DK1341522T3 - Mikropartikler med forbedret frigivelsesprofil og Fremgangsmåde til deres fremstilling - Google Patents

Mikropartikler med forbedret frigivelsesprofil og Fremgangsmåde til deres fremstilling

Info

Publication number
DK1341522T3
DK1341522T3 DK01984822T DK01984822T DK1341522T3 DK 1341522 T3 DK1341522 T3 DK 1341522T3 DK 01984822 T DK01984822 T DK 01984822T DK 01984822 T DK01984822 T DK 01984822T DK 1341522 T3 DK1341522 T3 DK 1341522T3
Authority
DK
Denmark
Prior art keywords
microparticles
preparation
release profile
enhanced release
present
Prior art date
Application number
DK01984822T
Other languages
Danish (da)
English (en)
Inventor
Thomas Kissel
Peter Schneider
Ruland Fridrich
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000161944 external-priority patent/DE10061944A1/de
Priority claimed from DE2001118160 external-priority patent/DE10118160A1/de
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Application granted granted Critical
Publication of DK1341522T3 publication Critical patent/DK1341522T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01984822T 2000-12-13 2001-12-11 Mikropartikler med forbedret frigivelsesprofil og Fremgangsmåde til deres fremstilling DK1341522T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2000161944 DE10061944A1 (de) 2000-12-13 2000-12-13 Mikropartikel mit verbessertem Freisetzungsprofil
DE2001118160 DE10118160A1 (de) 2001-04-11 2001-04-11 Chitosan enthaltende Mikropartikel

Publications (1)

Publication Number Publication Date
DK1341522T3 true DK1341522T3 (da) 2006-02-13

Family

ID=26007947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01984822T DK1341522T3 (da) 2000-12-13 2001-12-11 Mikropartikler med forbedret frigivelsesprofil og Fremgangsmåde til deres fremstilling

Country Status (20)

Country Link
US (1) US20040115277A1 (fr)
EP (1) EP1341522B1 (fr)
JP (1) JP2004515527A (fr)
AT (1) ATE309788T1 (fr)
AU (2) AU2002233239B2 (fr)
BG (1) BG107885A (fr)
BR (1) BR0116077A (fr)
CA (1) CA2431285A1 (fr)
CY (1) CY1105442T1 (fr)
CZ (1) CZ20031559A3 (fr)
DE (1) DE50108114D1 (fr)
DK (1) DK1341522T3 (fr)
EE (1) EE200300279A (fr)
ES (1) ES2250502T3 (fr)
HU (1) HUP0302363A3 (fr)
NO (1) NO20032657L (fr)
PL (1) PL363716A1 (fr)
RU (1) RU2291686C2 (fr)
SK (1) SK7172003A3 (fr)
WO (1) WO2002047664A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2570734A1 (fr) * 2004-06-28 2006-02-02 Cornell Research Foundation, Inc. Microspheres injectables a partir d'esters d'alcool polyhydriques fonctionnalises non satures
GB0416328D0 (en) * 2004-07-21 2004-08-25 Univ Cardiff Use of dry powder compositions for pulmonary delivery
EP1679065A1 (fr) * 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Formulation destinée à la libération contrôlée d'interferone par un copolymère bloc PEGT/PBT
US8628701B2 (en) * 2006-10-31 2014-01-14 Xavier University Of Louisiana Method of micro-encapsulation
UA90013C2 (ru) 2008-03-19 2010-03-25 Давид Анатолійович Нога Фармацевтическая композиция, содержащая инсулин, и способ его получения
WO2011163469A1 (fr) 2010-06-23 2011-12-29 Teva Pharmaceutical Industries Ltd. Forme hydratée du roflumilast-n-oxyde anti-inflammatoire
WO2013090634A1 (fr) 2011-12-14 2013-06-20 Abraxis Bioscience, Llc Utilisation d'excipients polymères pour la lyophilisation ou la congélation de particules
US9308172B2 (en) * 2012-10-26 2016-04-12 Board Of Trustees Of Michigan State University Device and method for encapsulation of hydrophilic materials
PL2987484T3 (pl) * 2013-04-18 2019-07-31 Shandong Luye Pharmaceutical Co., Ltd. Kompozycja farmaceutyczna mikrosfery o przedłużonym uwalnianiu gosereliny
PL3021873T3 (pl) 2013-07-18 2019-01-31 Xalud Therapeutics, Inc. Kompozycja do leczenia choroby zapalnej stawów
WO2015024759A1 (fr) * 2013-08-21 2015-02-26 Evonik Industries Ag Procédé de préparation de poudres redispersibles de polyesters biodégradables, insolubles dans l'eau

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3116311B2 (ja) * 1990-06-13 2000-12-11 エーザイ株式会社 マイクロスフィアの製法
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
PT669128E (pt) * 1992-11-17 2000-06-30 Yoshitomi Pharmaceutical Micro-esfera de libertacao sustentada contendo antipsicoticos e processo para produzir a mesma
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
JPH08511418A (ja) * 1993-04-19 1996-12-03 メディソーブ・テクノロジーズ・インターナショナル・リミテッド・パートナーシップ 生分解性極微粒子からのアンチセンスオリゴデオキシリボヌクレオチドの徐放運搬による長期作用のある処置
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
CA2213906A1 (fr) * 1996-09-23 1998-03-23 Dusica Maysinger Composition pharmaceutique et methode pour sauvegarder les neurones au cours d'un accident cerebro-vasculaire ischemique
KR100289471B1 (ko) * 1998-01-19 2001-09-17 김충섭 휀타닐계마취제의이식형서방성제제
US6194006B1 (en) * 1998-12-30 2001-02-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of microparticles having a selected release profile
EP1044683A1 (fr) * 1999-04-15 2000-10-18 Debio Recherche Pharmaceutique S.A. Procédé de dispersion à une étape pour la microencapsulation de substances solubles dans l'eau

Also Published As

Publication number Publication date
BG107885A (bg) 2004-01-30
WO2002047664A2 (fr) 2002-06-20
AU2002233239B2 (en) 2006-05-11
BR0116077A (pt) 2004-02-17
SK7172003A3 (en) 2004-05-04
HUP0302363A3 (en) 2006-07-28
ES2250502T3 (es) 2006-04-16
JP2004515527A (ja) 2004-05-27
RU2291686C2 (ru) 2007-01-20
EE200300279A (et) 2003-10-15
PL363716A1 (en) 2004-11-29
HUP0302363A2 (hu) 2003-10-28
NO20032657D0 (no) 2003-06-12
WO2002047664A8 (fr) 2004-03-04
CZ20031559A3 (cs) 2004-03-17
ATE309788T1 (de) 2005-12-15
CY1105442T1 (el) 2010-04-28
CA2431285A1 (fr) 2002-06-20
DE50108114D1 (de) 2005-12-22
HK1054689A1 (en) 2003-12-12
US20040115277A1 (en) 2004-06-17
AU3323902A (en) 2002-06-24
EP1341522A2 (fr) 2003-09-10
WO2002047664A3 (fr) 2002-12-27
EP1341522B1 (fr) 2005-11-16
NO20032657L (no) 2003-07-18

Similar Documents

Publication Publication Date Title
WO2004062577A3 (fr) Utilisation d'un melange de deux ou de plusieurs materiaux enteriques afin de reguler la liberation de medicaments via une membrane ou une matrice dans des therapies systemiques
DE60135872D1 (de) Absackbekämpfung bei isorohren, die bei der herstellung von flachglas nach dem schmelzverfahren verwendet werden
ZA200301813B (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
WO2001079460A3 (fr) Polypeptides a activite haloperoxydase
DE60231395D1 (de) Dezellularisierung von gewebematrixen
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
DK1341522T3 (da) Mikropartikler med forbedret frigivelsesprofil og Fremgangsmåde til deres fremstilling
YU31000A (sh) Sferoidi, postupak za dobijanje i farmaceutske kompozicije
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
DK1399133T4 (da) Sammensætning med langvarig frigivelse omfattende mælkesyre-glykolsyre-copolymer samt fremgangsmåde til fremstilling heraf
WO2006072347A3 (fr) Thiophene substitue par un alkinyle
WO2003057150A3 (fr) Formulation pharmaceutique d'hydrochlorure stable et procédé de préparation
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff
ITMI20001093A0 (it) Composizioni a rilascio controllato contenenti un principio attivo, preferibilmente melatonina, e processo di preparazione delle stesse.
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
GB0004827D0 (en) Compositions
GB0216002D0 (en) Process and composition
HUP0301072A3 (en) Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient
FR2894143B1 (fr) Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
WO2004017938A3 (fr) Forme galenique a liberation controlee de nitrofurantoine
PL378106A1 (pl) Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem
HRP20050055B1 (hr) Mikrokapsule za odloženo i kontrolirano oslobađanje perindoprila
AU2003246840A8 (en) Anti-hiv composition, production method thereof and medicament
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same